Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Baillie Gifford & Co.

Baillie Gifford & Co. trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 20.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 170,750 shares of the biotechnology company’s stock after selling 45,174 shares during the period. Baillie Gifford & Co. owned approximately 0.22% of Axon Enterprise worth $101,480,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in AXON. Strategic Advisors LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at $254,000. Spectrum Wealth Advisory Group LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at $267,000. J.W. Cole Advisors Inc. increased its holdings in Axon Enterprise by 87.7% in the 4th quarter. J.W. Cole Advisors Inc. now owns 5,870 shares of the biotechnology company’s stock valued at $3,489,000 after purchasing an additional 2,742 shares in the last quarter. Nkcfo LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at $166,000. Finally, J.P. Marvel Investment Advisors LLC purchased a new position in Axon Enterprise in the 4th quarter valued at about $6,485,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the sale, the insider now owns 124,243 shares in the company, valued at $77,586,026.21. The trade was a 0.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock valued at $5,631,561 over the last quarter. Insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. JMP Securities upped their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. Robert W. Baird upped their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $683.41 on Tuesday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm’s 50-day moving average price is $624.03 and its two-hundred day moving average price is $511.87. Axon Enterprise, Inc. has a 52-week low of $260.27 and a 52-week high of $698.67. The stock has a market capitalization of $52.11 billion, a P/E ratio of 176.59, a P/E/G ratio of 6.79 and a beta of 1.05.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.